Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.
The Food and Drug Administration (FDA) has cleared an investigational new drug application for the novel treatment, APTN-101, ...
adaptive behavior and tremor” and went ahead with filing a new drug application with the FDA. Applied had planned to ask for U.S. approval on the strength of biomarker data, only for the FDA to ...
The licenses, intended for small and minority-owned businesses, were awarded to LLCs tied to a Wyoming company whose true ...
The unintended consequences of legislation are often as important as the original purpose. Two bills scheduled to be ...
A drug currently used to treat HIV has also been found to dramatically reduce the risk of infection, significantly more than the primary option available for pre-exposure prophylaxis or PrEP.
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
A 35-year-old Blarney woman charged with possession of heroin for sale or supply was charged on Wednesday with a new ...
Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to ...
Indies Pharma Jamaica Limited has made history as it became the first Jamaican company to get an ANDA (Abbreviated New Drug Application) approved by the United States Food and Drug Administration ...
Civil Society Organisations oppose Gilead's patent applications for lenacapavir in India: Our Bureau, New Delhi Tuesday, September 17, 2024, 15:40 Hrs [IST] Civil society organisa ...
Civil society organisations opposing the patent applications of US-based pharma major Gilead ... According to UNAIDS, this new HIV drug can offer hope of ending AIDS if all have access. Lenacapavir, ...